Stage IVA Laryngeal Cancer AJCC v8

specific

Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and

69

Centers

105

Active Trials

Cancer Funding

Top Centers for Stage IVA Laryngeal Cancer AJCC v8(69)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
171.6
2
NCI Comprehensive
High-Volume Research Center
71.6
3
NCI Comprehensive
High-Volume Research Center
71.6
4
NCI Comprehensive
High-Volume Research Center
71.6
5
High-Volume Research Center
71.6
6
NCI Comprehensive
Active Research Program
68.0
7
NCI Comprehensive
Active Research Program
68.0
8
NCI Comprehensive
Active Research Program
68.0
9
NCI Comprehensive
Active Research Program
68.0
10
Active Research Program
68.0
11
Active Research Program
68.0
12
NCI Comprehensive
Active Research Program
60.2
13
NCI Comprehensive
Active Research Program
60.2
14
NCI Comprehensive
Active Research Program
60.2
15
NCI Comprehensive
Active Research Program
60.2
16
NCI Comprehensive
Active Research Program
60.2
17
NCI Comprehensive
Active Research Program
60.2
18
NCI Clinical
Active Research Program
60.2
19
Active Research Program
60.2
20
Active Research Program
60.2
21
NCI Clinical
Active Research Program
60.2
22
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
60.2
23
NCI Comprehensive
Active Research Program
60.2
24
Active Research Program
60.2
25
Active Research Program
60.2
26
NCI Comprehensive
Active Research Program
60.2
27
Active Research Program
60.2
28
Active Research Program
60.2
29
Active Research Program
60.2
30
NCI Comprehensive
Active Research Program
44.2
31
NCI Comprehensive
Active Research Program
44.2
32
NCI Comprehensive
Active Research Program
44.2
33
NCI Comprehensive
Active Research Program
44.2
34
NCI Comprehensive
Active Research Program
44.2
35
NCI Comprehensive
Active Research Program
44.2
36
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.2
37
NCI Comprehensive
Active Research Program
44.2
38
NCI Comprehensive
Active Research Program
44.2
39
NCI Comprehensive
Active Research Program
44.2
40
NCI Comprehensive
Active Research Program
44.2
41
NCI Comprehensive
Active Research Program
44.2
42
NCI Comprehensive
Active Research Program
44.2
43
NCI Comprehensive
Active Research Program
44.2
44
NCI Comprehensive
Active Research Program
44.2
45
NCI Comprehensive
Active Research Program
44.2
46
NCI Comprehensive
Active Research Program
44.2
47
NCI Comprehensive
Active Research Program
44.2
48
NCI Comprehensive
Active Research Program
44.2
49
NCI Clinical
Active Research Program
44.2
50
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
44.2
5144.2
52
Active Research Program
44.2
53
Active Research Program
44.2
54
NCI Basic_laboratory
Active Research Program
44.2
55
Active Research Program
44.2
56
Active Research Program
44.2
57
Active Research Program
44.2
58
Active Research Program
44.2
59
Active Research Program
44.2
60
Active Research Program
44.2
61
NCI Comprehensive
31.2
62
NCI Comprehensive
31.2
63
NCI Comprehensive
31.2
64
NCI Comprehensive
31.2
65
NCI Comprehensive
31.2
66
Cedars-Sinai CancerLos Angeles, CA
31.2
6731.2
6831.2
6931.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →